Extracorporeal Membrane Oxygenation Machine Market by Modality (Arteriovenous ECMO, Venoarterial ECMO, Venovenous ECMO), Age (Adult, Neonate, Pediatric), Component, Application, End-User - Global Forecast 2024-2030
Description
Extracorporeal Membrane Oxygenation Machine Market by Modality (Arteriovenous ECMO, Venoarterial ECMO, Venovenous ECMO), Age (Adult, Neonate, Pediatric), Component, Application, End-User - Global Forecast 2024-2030
The Extracorporeal Membrane Oxygenation Machine Market size was estimated at USD 794.86 million in 2023 and expected to reach USD 832.14 million in 2024, at a CAGR 4.55% to reach USD 1,085.63 million by 2030.
Extracorporeal membrane oxygenation machines are medical devices that provide prolonged cardiac & respiratory support for patients whose hearts and lungs cannot provide adequate gas exchange to sustain life. These machines extract blood from the patient’s body, oxygenate it through an artificial lung (the membrane), remove carbon dioxide, and then return it to the patient’s bloodstream. This external life support system takes over the function of the heart and lungs, allowing these organs to rest and heal during critical illness. The surging prevalence of cardiovascular and respiratory diseases and technological advancements that improve patient outcomes have increased the adoption of ECMO systems. Additionally, improvements in healthcare infrastructure and increased healthcare spending are contributing to the market expansion. High costs associated with ECMO procedures and a limited number of trained healthcare professionals to operate these machines represent a challenge for market growth. Nevertheless, advancements in ECMO machine design to enhance portability and ease of use in different treatment settings are expected to provide opportunistic scope for the market. Moreover, ECMO integration with other extracorporeal therapies and research activities focused on expanding the indications for ECMO support is expected to boost the market.
Regional Insights
In the Americas region, extracorporeal membrane oxygenation machines have seen significant growth driven by the high incidence rates of cardiovascular and respiratory diseases, a well-established healthcare infrastructure system, and the availability of skilled professionals. Additionally, the region has seen a surge in ECMO utilization due to the COVID-19 pandemic, further fueling market expansion. Increased funding for research and development, coupled with technological advancements, continues to enhance ECMO system capabilities, making them more efficient and user-friendly for critical care adoption. The market landscape for ECMO machines in the EMEA region exhibits steady growth. In Europe, the demand for ECMO support is influenced by rising healthcare expenditures, an aging population, and the prevalence of lifestyle-associated diseases. Major economies are implementing ECMOs due to their advanced healthcare systems and policies that favor adopting medical devices. The Asia-Pacific region shows high-growth prospects for ECMO machines. Economic development, increasing healthcare expenditure, and a growing population base are pivotal forces propelling market growth. Major economies are investing heavily in upgrading their healthcare infrastructure. Moreover, the boosting medical tourism industry in some economies is also opening new avenues for the ECMO machines market.
Market Insights
- Market Dynamics
The market dynamics represent an ever-changing landscape of the Extracorporeal Membrane Oxygenation Machine Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.- Market Drivers
- Prevalence of cardiovascular and respiratory diseases
- Adoption of ECMO for neonatal care and expansion of ECMO centers
- Market Restraints
- Adverse recalls of ECMO machines
- Market Opportunities
- Ongoing advancements in ECMO machines
- Improving reimbursement scenario for ECMO machines worldwide
- Market Challenges
- Potential complexity associated with the operation and maintenance of ECMO
- Market Segmentation Analysis
- Modality: Rising utilization of venoarterial ECMO as it provides both cardiac and respiratory support
- Age: Increasing need for ECMO machines in adults owing to respiratory & cardiac disorders
- Component: Increasing need for durable and biocompatible oxygenators for ECMO machines
- Application: Proliferating usage of Extracorporeal Cardiopulmonary Resuscitation (ECPR) as it quickly restores oxygenated blood flow to vital organs
- End-User: Development of advanced ECMO machines to cater to dedicated intensive care units in hospitals
- Market Disruption Analysis
- Porter’s Five Forces Analysis
- Value Chain & Critical Path Analysis
- Pricing Analysis
- Technology Analysis
- Patent Analysis
- Trade Analysis
- Regulatory Framework Analysis
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Extracorporeal Membrane Oxygenation Machine Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Extracorporeal Membrane Oxygenation Machine Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments- The Government of New South Wales (NSW)’s New Innovative Clinical Trial with Mobile Cardiac Treatment
The New South Wales (NSW) Government invested significantly in the healthcare sector by allocating funds to acquire state-of-the-art Extracorporeal Membrane Oxygenation (ECMO) machines. These sophisticated devices offer critical life support to patients experiencing severe heart and lung failure, effectively substituting their functions to allow for recovery or while awaiting a transplant. This initiative aligns with the NSW Government's commitment to providing advanced medical treatments and improving patient outcomes across the state.
Inspira Technologies Unveils the INSPIRA ART Line of Medical Devices at the World's Largest Extracorporeal Life Support Conference
Inspira Technologies OXY B.H.N. Ltd. introduced its INSPIRA ART product suite during the Extracorporeal Life Support Organization (ELSO) Conference held in Seattle, Washington. This lineup features the innovative INSPIRA ART100, a cardio-pulmonary bypass (CPB) apparatus designed to support patients undergoing CPB interventions. The suite also showcases the INSPIRA ART500, a groundbreaking device engineered to transform the treatment landscape for approximately 20 million individuals who struggle with severe breathing complications annually.
AIIMS-R Starts ECMO Treatment
AIIMS Raipur commenced the provision of Extracorporeal Membrane Oxygenation (ECMO) therapy, a sophisticated life support intervention, catering to patients with severe and life-threatening illnesses affecting the heart and lungs. This cutting-edge medical procedure offers a critical lifeline by oxygenating a patient's blood outside the body, thus allowing the heart and lungs to rest and heal. Implementing ECMO services at AIIMS Raipur signifies a substantial advancement in the region's healthcare facilities. It extends a beacon of hope to critically ill patients who previously had limited access to such high-end treatment options.
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Extracorporeal Membrane Oxygenation Machine Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Extracorporeal Membrane Oxygenation Machine Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abiomed, Inc., Baxter International Inc., Braile Biomédica, Chalice Medical Ltd., CytoSorbents Corporation, Dragerwerk AG & Co. KGaA, Eurosets S.R.L., Getinge AB, Guangdong Pigeon Medical Apparatus Co.,Ltd., Hengko Technology Co., Ltd., Inspira Technologies OXY B.H.N. Ltd., LivaNova PLC, MC3 Cardiopulmonary, Medtronic PLC, MicroPort Scientific Corporation, Nipro Corporation, Origen Biomedical, Inc., Owgels Group, Senko Medical Instrument Mfg. Co., Ltd., Shenzhen Mindray Biomedical Electronics Co. Ltd., Technimount System, Terumo Corporation, XENIOS AG by Fresenius Medical Care AG & Co. KGaA, and ZOLL Medical Corporation by Asahi Kasei Corporation.
Market Segmentation & Coverage
This research report categorizes the Extracorporeal Membrane Oxygenation Machine Market to forecast the revenues and analyze trends in each of the following sub-markets:- Modality
- Arteriovenous ECMO
- Venoarterial ECMO
- Venovenous ECMO
- Age
- Adult
- Neonate
- Pediatric
- Component
- Anticoagulation Systems
- Blender
- Cannulae
- Heat Exchanger
- Monitoring Systems
- Oxygenator
- Pump
- Application
- Cardiac Application
- Extracorporeal Cardiopulmonary Resuscitation
- Respiratory Application
- End-User
- Ambulatory Surgical Centers
- Hospitals
- Specialty Clinics
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
Please Note: PDF & Excel + Online Access - 1 Year
- Americas
- Market Drivers
Table of Contents
193 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Prevalence of cardiovascular and respiratory diseases
- 5.1.1.2. Adoption of ECMO for neonatal care and expansion of ECMO centers
- 5.1.2. Restraints
- 5.1.2.1. Adverse recalls of ECMO machines
- 5.1.3. Opportunities
- 5.1.3.1. Ongoing advancements in ECMO machines
- 5.1.3.2. Improving reimbursement scenario for ECMO machines worldwide
- 5.1.4. Challenges
- 5.1.4.1. Potential complexity associated with the operation and maintenance of ECMO
- 5.2. Market Segmentation Analysis
- 5.2.1. Modality: Rising utilization of venoarterial ECMO as it provides both cardiac and respiratory support
- 5.2.2. Age: Increasing need for ECMO machines in adults owing to respiratory & cardiac disorders
- 5.2.3. Component: Increasing need for durable and biocompatible oxygenators for ECMO machines
- 5.2.4. Application: Proliferating usage of Extracorporeal Cardiopulmonary Resuscitation (ECPR) as it quickly restores oxygenated blood flow to vital organs
- 5.2.5. End-User: Development of advanced ECMO machines to cater to dedicated intensive care units in hospitals
- 5.3. Market Trend Analysis
- 5.3.1. Established healthcare infrastructure and focused on specialized research efforts across the Americas
- 5.3.2. Increasing deployment of ECMO machines with rising investment for improving healthcare infrastructure across the APAC region
- 5.3.3. Increasing research activities for evaluating effectiveness, coupled with growing ECMO programs and training in the EMEA region
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework Analysis
- 6. Extracorporeal Membrane Oxygenation Machine Market, by Modality
- 6.1. Introduction
- 6.2. Arteriovenous ECMO
- 6.3. Venoarterial ECMO
- 6.4. Venovenous ECMO
- 7. Extracorporeal Membrane Oxygenation Machine Market, by Age
- 7.1. Introduction
- 7.2. Adult
- 7.3. Neonate
- 7.4. Pediatric
- 8. Extracorporeal Membrane Oxygenation Machine Market, by Component
- 8.1. Introduction
- 8.2. Anticoagulation Systems
- 8.3. Blender
- 8.4. Cannulae
- 8.5. Heat Exchanger
- 8.6. Monitoring Systems
- 8.7. Oxygenator
- 8.8. Pump
- 9. Extracorporeal Membrane Oxygenation Machine Market, by Application
- 9.1. Introduction
- 9.2. Cardiac Application
- 9.3. Extracorporeal Cardiopulmonary Resuscitation
- 9.4. Respiratory Application
- 10. Extracorporeal Membrane Oxygenation Machine Market, by End-User
- 10.1. Introduction
- 10.2. Ambulatory Surgical Centers
- 10.3. Hospitals
- 10.4. Specialty Clinics
- 11. Americas Extracorporeal Membrane Oxygenation Machine Market
- 11.1. Introduction
- 11.2. Argentina
- 11.3. Brazil
- 11.4. Canada
- 11.5. Mexico
- 11.6. United States
- 12. Asia-Pacific Extracorporeal Membrane Oxygenation Machine Market
- 12.1. Introduction
- 12.2. Australia
- 12.3. China
- 12.4. India
- 12.5. Indonesia
- 12.6. Japan
- 12.7. Malaysia
- 12.8. Philippines
- 12.9. Singapore
- 12.10. South Korea
- 12.11. Taiwan
- 12.12. Thailand
- 12.13. Vietnam
- 13. Europe, Middle East & Africa Extracorporeal Membrane Oxygenation Machine Market
- 13.1. Introduction
- 13.2. Denmark
- 13.3. Egypt
- 13.4. Finland
- 13.5. France
- 13.6. Germany
- 13.7. Israel
- 13.8. Italy
- 13.9. Netherlands
- 13.10. Nigeria
- 13.11. Norway
- 13.12. Poland
- 13.13. Qatar
- 13.14. Russia
- 13.15. Saudi Arabia
- 13.16. South Africa
- 13.17. Spain
- 13.18. Sweden
- 13.19. Switzerland
- 13.20. Turkey
- 13.21. United Arab Emirates
- 13.22. United Kingdom
- 14. Competitive Landscape
- 14.1. Market Share Analysis, 2023
- 14.2. FPNV Positioning Matrix, 2023
- 14.3. Competitive Scenario Analysis
- 14.3.1. The Government of New South Wales (NSW)’s New Innovative Clinical Trial with Mobile Cardiac Treatment
- 14.3.2. Inspira Technologies Unveils the INSPIRA ART Line of Medical Devices at the World's Largest Extracorporeal Life Support Conference
- 14.3.3. AIIMS-R Starts ECMO Treatment
- 14.3.4. MGM Healthcare Inaugurates Advanced ECMO Care Facility for Children
- 14.3.5. Abbott's Life Support System Receives New FDA Clearances to Help Doctors Treat More Critically Ill Patients
- 14.3.6. First Domestic ECMO Machine to Play Vital Role
- 14.3.7. China Grants Market Approval to Self-Developed ECMO Device for Severe COVID-19 Cases
- 15. Competitive Portfolio
- 15.1. Key Company Profiles
- 15.2. Key Product Portfolio
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
